IRCT20220123053807N1招募中3 期
Comparison of the effect tocilizumab, plasmapheresis and tocilizumab plasmapheresis combination in Coronavirus disease (COVID -19) patients admitted to the intensive care unit
Yazd University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 68 years（—）
- 性别
- All
入选标准
- •All patients with Coronavirus disease (COVID-19) admitted to intensive care units
- •diagnosis of Covid-19 based on Polymerase chain reaction (PCR) of nasopharyngeal
- •Serum C-reactive protein (CRP) and interleukin 6 levels are at least twice normal
- •Oxygen saturation (o2sat) more than 80% without supplemental oxygen or Respiratory Rate (RR) more than 24
排除标准
- •History of drug allergy
- •Platelets less than 50000
- •Suspected by active viral (Non-COVID), bacterial and fungal infections
- •Primary intubation
- •absolute neutrophil count (ANC) less than 500
- •Any clinical suspicion of gastrointestinal obstruction
- •Pregnancy and lactation
- •Patient or family dissatisfaction
研究者
相似试验
尚未招募
不适用
Comparisson of the effectiveness of Tocilizumab and Tofacitinib on the outcomes of patients with severe COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20210901052358N3Shahid Beheshti University of Medical Sciences60
已完成
2 期
A comparative study of the effects of Tocilizumab?, interferon-gamma and vitamin C on the recovery of critically ill Covid-19 patients and cytokine stormCovid-19.Covid-19 diseaseU07.1IRCT20200525047570N1Tabriz University of Medical Sciences60
已完成
2 期
Effect of TOCILIZUMAB (ACTEMRA) on treatment of COVID-19COVID-19 disease.COVID-19, virus not identifiedU07.2IRCT20081027001411N4Tehran University of Medical Sciences40
招募中
2 期
Clinical trial of tocilizumab versus cyclophosphamide for microscopic polyangiitis and granulomatosis with polyangiitisMicroscopic polyangiitis (MPA) Granulomatosis with polyangiitis (GPA)JPRN-jRCT1091220325Masayoshi Harigai48
招募中
2 期
Clinical trial of tocilizumab versus cyclophosphamide for microscopic polyangiitis and granulomatosis with polyangiitisMicroscopic polyangiitis (MPA) Granulomatosis with polyangiitis (GPA)JPRN-UMIN000024574Tokyo women's medical university Institute of rheumatology48